Solis Pharmaceuticals

Hyderabad, India Founded: 2021 • Age: 5 yrs Acquired By PI Health Sciences
Manufacturer of drugs
Annual revenue $950,804 Latest available
Total funding - Funding intelligence
Employees 42 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Solis Pharmaceuticals

Solis Pharmaceuticals is a company based in Hyderabad (India) founded in 2021 was acquired by PI Health Sciences in June 2023. The company has 42 employees as of April 08, 2024.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $950.8 K (USD)
    6.93
    as on Mar 31, 2023
  • Net Profit
    $17.03 K (USD)
    -16.81
    as on Mar 31, 2023
  • EBITDA
    $72.97 K (USD)
    -4.91
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    42

    as on Apr 08, 2024

  • Acquired by
    PI Health Sciences

    (Jun 05, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Solis Pharmaceuticals

Investors in Solis Pharmaceuticals

Solis Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include PI Health Sciences.

All
Investor Description Founded Year Domain Location
Specializes in CRO and CDMO services for medicinal chemistry and API manufacturing.
Founded Year Domain Location

Investments & Acquisitions by Solis Pharmaceuticals

Investments

Financial Statements - Solis Pharmaceuticals

Solis Pharmaceuticals Comparisons

+
Add Comparison
Available on Premium

Competitors of Solis Pharmaceuticals

Latest news on Solis Pharmaceuticals

Frequently Asked Questions about Solis Pharmaceuticals

Solis Pharmaceuticals was founded in 2021.

Solis Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Apr 08, 2024, the latest employee count at Solis Pharmaceuticals is 42.

Annual revenue of Solis Pharmaceuticals is $950.8K as on Mar 31, 2023.

Solis Pharmaceuticals, established in 2021, excels in providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

Solis Pharmaceuticals has 1 investor. Key investors include PI Health Sciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available